Subscribe to our Newsletter!
Cerca
Solutions
Innovation
Knowledge
People
Contact Us
EN
中文 日本
Solutions
Innovation
Knowledge
People

By Approach

Clinical Labs Business Alliances Industrial World

By Trending Field

Respiratory Infections Antibiotic Resistances Clinical Automation Molecular Biology All Applications Fields
All Products

Copan Technologies

WISE approach FLOQ® Technology LBM® technology Digital Microbiology

Programs

Quality First Science and R&D Futura Invent

Sharing

Blog & News Events and Fairs

Resources

e-labelling Quality Certificates Certificates of Analysis Patents Trademarks

More Than Just a Brand

About Working at Copan

Get Involved

Open Positions Contacts
Solutions

By Approach

Clinical Labs Business Alliances Industrial World

By Trending Field

Respiratory Infections Antibiotic Resistances Clinical Automation Molecular Biology All Applications Fields
All Products
Innovation

Copan Technologies

WISE approach FLOQ® Technology LBM® technology Digital Microbiology

Programs

Quality First Science and R&D Futura Invent
Knowledge

Sharing

Blog & News Events and Fairs

Resources

e-labelling Quality Certificates Certificates of Analysis Patents Trademarks
People

More Than Just a Brand

About Working at Copan

Get Involved

Open Positions Contacts
Contact Us
EN
中文 日本

Search results for:

Copan Group
Scientific Studies (11)
News (1)

Scientific study

PLoS One
2020
Nasopharyngeal
Molecular biology
Respiratory Infection
Healthcare worker

Pneumococcal colonization prevalence and density among Thai children with severe pneumonia and community controls

Barameht Piralam, Christine Prosperi, Somsak Thamthitiwat, Charatdao Bunthi, Pongpun Sawatwong, Ornuma Sangwichian, Melissa M. Higdon, Nora L. Watson, Maria Deloria Knoll, Wantana Paveenkittiporn, Chuwattana Chara, Cameron P. Hurst, Pasakorn Akarasewi, Julia Rhodes, Susan A. Maloney, Katherine L. O’Brien, Henry C. Baggett
Source

Scientific study

Clinical Microbiology and Infection
2018
Nasopharyngeal
Molecular biology
Respiratory Infection
Healthcare worker

Prevalence and clinical significance of respiratory viruses and bacteria detected in tuberculosis patients compared to household contact controls in Tanzania: a cohort study

Mhimbira F.
Source

Scientific study

Sultan Qaboos University Med Journal
2020
Swab
Nasopharyngeal
Molecular biology
Respiratory Infection

Nasopharyngeal Isolates from a Cohort of medical students with or without pharyngitis

Hassib Narchi
Source

Scientific study

Diagnostic Microbiology and Infectious Disease
2021
Swab
staphylococcus aureus
Molecular biology
Respiratory Infection

Laboratory evaluation of the BioFire FilmArray Pneumonia plus panel compared to conventional methods for the identification of bacteria in lower respiratory tract specimens: a prospective cross-sectional study from South Africa

Barend Mitton
Source

Scientific study

PLoS One
2018
Nasopharyngeal
Respiratory Infection
Healthcare worker
HCW

Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands

Marloes Vissers
Source

Scientific study

Journal of Clinical Microbiology
2021
Self Collection
Nasal
Sars-Cov-2
Molecular biology

Comparable specimen collection from both ends of at-home mid-turbinate swabs

Melissa Truong
Source

Scientific study

Open Forum Infectious Diseases
2018
Swab
mrsa
eswab
staphylococcus aureus

Performance of TEM-PCR vs Culture for Bacterial Identification in Pediatric Musculoskeletal Infections

James B. Wood
Source

Scientific study

Plos One
2016
Transystem™
Nasopharyngeal
Respiratory Infection
Healthcare worker

Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines

Adamos Hadjipanayis
Source

Scientific study

BMC Pregnancy Childbirth
2018
Transystem™
Vaginal
Swab
Molecular biology

Development of a melting-curve based multiplex real-time PCR assay for simultaneous detection of Streptococcus agalactiae and genes encoding resistance to macrolides and lincosamides

Eliane Saori Otaguiri
Source

Scientific study

Plos One
2019
Transystem™
Swab
Healthcare worker
HCW

Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine

Corinne Levy
Source

Scientific study

Plos one
2024
AMR
Infants
Streptococcus pneumoniae
MDRO

Serotype epidemiology and antibiotic resistance of pneumococcal isolates colonizing infants in Botswana (2016–2019)

Jillian H. Hurst et al.

Source

Microbiology Time

August 1, 2024
Genetics
HPV
Human Papillomavirus
screening

Microbiology Time – August 2024

To select this month’s studies, we’ve traveled to three continents with an epidemiology study on pneumococcus in Botswana, an update on the British HPV screening program YouScreen, and an E. coli sequencing project in Pakistan.

Read more
Copan Group
Any content
Product Code

I'm looking for...

Any content
Product code
Any Content
Product Code

Popular search

Self FLOQ Rapid AST

Solutions

Clinical lab Clinical Business Industrial world
Close Search

We love to talk
to people

Write us to satisfy your curiosity, get information or start a great collaboration!

Contact us for more info

Are you looking
for something?

Use our search tool and be surprised by how easy it is to get right to the point.

Search

About

Company Contacts Press Releases Work with us Sustainability Report HSE Policy

Solutions

Clinical Labs Business Alliances Industrial World All products

Innovation

WISE approach FLOQ® Technology LBM® technology Digital Microbiology Quality First Science & R&D Futura Invent

Knowledge

Blog & News Events and Fairs

Resources

e-labelling Quality Certificates Certificates of Analysis Patents Trademarks

Ethics & Compliance

PSCL Model 231 Conditions of Use Privacy Transparency Report Whistleblowing
EN
中文 日本
COPAN ITALIA spa Via F. Perotti 10, 25125 Brescia - Italy
C.F. e numero iscrizione Registro delle Imprese di Brescia: 01740560170. -P. IVA - ID VAT nr. IT 01740560170
Capitale sociale € 6.000.000 I.V.
copan group
copan group
copan group

Contact

Thank you!Your submission
has been received!
Oops! Something went wrong while submitting the form.

Newsletter

Thank you!Your submission
has been received!
Oops! Something went wrong while submitting the form.